Penumbra Inc (NYSE:PEN)
227.56 USD
-8.820 3.731%Previous Close (in USD) | 236.38 |
---|---|
Change | -8.820 3.731% |
52 W H/L (in USD) | 348.670/180.930 |
EBITDA (in USD) | 86.529M |
PE Ratio | 243.94 |
Volume | 306691 |
Diluted Eps TTM | 1.06 |
Total Assets (in USD) | 1370.886M |
---|---|
Total Liabilities (in USD) | 372.028M |
Revenue TTM (in USD) | 995.059M |
Cash (in USD) | 69.858M |
Market Cap (in USD) | 9,980.256 M |
Revenue Per Share TTM | 26.014 |
Gross Profit TTM (in USD) | 535.207M |
Summary
Income Statement
Balance Sheet
Change in Cash
Operating Cash
Penumbra Inc
Employees: 3900
Key Executives
Sr. No. | Name | Title | Year Born |
---|---|---|---|
1. | Mr. Adam Elsesser | Co-Founder, Chairman, Pres & CEO | 1962 |
2. | Dr. Arani Bose M.D. | Co-Founder & Director | 1962 |
3. | Ms. Maggie S. Yuen | Chief Financial Officer | 1972 |
4. | Mr. Lambert Shiu | Chief Accounting Officer | 1980 |
5. | Ms. Johanna Roberts | Exec. VP, Gen. Counsel & Sec. | 1972 |
6. | Ms. Lynn Rothman | Exec. VP & Chief Bus. Officer | 1961 |
7. | Mr. Ben Sorci | Exec. VP of Operations | NA |
8. | Mr. Pankaj Tiwari | Exec. VP & Chief Information Officer | NA |
9. | Ms. Jee Hamlyn-Harris | Investor Relations Officer | NA |
10. | Ms. Shruthi Narayan | Director of Marketing - Vascular | NA |
Peers
Sector: Healthcare
Industry: Medical Devices
Company | Change (USD) | Price (USD) | Trailing PE(x) | Forward PE(x) | Price Sales TTM(x) | Price to Book Value(x) | Enterprise Value to Revenue(x) | Enterprise Value to EBITDA(x) |
ABT
Abbott Laboratories |
+0.010 0.009% | 111.95 | 37.150 | 23.148 | 4.666 | 4.975 | 4.878 | 19.381 |
SYK
Stryker Corporation |
+0.320 0.091% | 353.96 | 44.070 | 24.938 | 5.509 | 6.118 | 6.050 | 25.731 |
MDT
Medtronic PLC |
+0.060 0.072% | 83.57 | 26.600 | 15.873 | 3.354 | 2.083 | 3.897 | 14.117 |
BSX
Boston Scientific Corp |
+0.120 0.178% | 67.43 | 68.170 | 24.570 | 5.855 | 4.265 | 6.462 | 26.799 |
Income Statement
(Currency in USD)Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
---|---|---|---|---|---|
Income Before Tax | 3.892M | -10.502M | -38.018M | 50.135M | 1.608M |
Minority Interest | 0M | 2.661M | -3.555M | -0.279M | 0.175M |
Net Income | -2.002M | 2.623M | -19.257M | 48.458M | 6.601M |
Selling General Administrative | 449.718M | 378.331M | 287.068M | 272.733M | 226.385M |
Gross Profit | 535.207M | 475.382M | 338.175M | 371.964M | 292.533M |
Reconciled Depreciation | 24.321M | 16.408M | 12.891M | 8.104M | 6.168M |
Ebit | -18.239M | -23.909M | -51.833M | 39.404M | 54.65M |
Ebitda | 6.082M | -7.501M | -38.942M | 47.508M | 60.818M |
Depreciation And Amortization | 24.321M | 16.408M | 12.891M | 8.104M | 6.168M |
Operating Income | -18.239M | -7.501M | -38.942M | 47.508M | -0.852M |
Other Operating Expenses | 841.051M | 755.091M | 599.354M | 499.897M | 414.955M |
Interest Expense | 0.137M | 16.068M | 17.37M | 12.185M | 0M |
Tax Provision | 5.894M | -13.125M | -18.761M | 3.131M | -4.478M |
Interest Income | 0.137M | 0.938M | 1.267M | 2.854M | 2.964M |
Net Interest Income | 0.137M | 0.938M | 1.267M | 2.854M | 2.964M |
Income Tax Expense | 5.894M | -13.125M | -18.761M | 3.131M | -4.403M |
Total Revenue | 847.133M | 747.59M | 560.412M | 547.405M | 444.938M |
Total Operating Expenses | 529.125M | 482.883M | 377.117M | 324.456M | 262.55M |
Cost Of Revenue | 311.926M | 272.208M | 222.237M | 175.441M | 152.405M |
Total Other Income Expense Net | 22.131M | -3.001M | 0.924M | 2.627M | -31.339M |
Net Income From Continuing Ops | -2.002M | 2.623M | -19.257M | 47.004M | 2.91M |
Net Income Applicable To Common Shares | -2.002M | 5.284M | -15.702M | 48.458M | 6.601M |
Balance Sheet
(Currency in USD)Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
---|---|---|---|---|---|
Total Assets | 1370.886M | 1244.25M | 822.983M | 665.901M | 515.006M |
Intangible Assets | 81.161M | 90.618M | 10.639M | 25.407M | 27.245M |
Other Current Assets | 30.279M | 29.155M | 18.735M | 14.852M | 12.2M |
Total Liab | 372.028M | 290.323M | 185.195M | 180.288M | 92.591M |
Total Stockholder Equity | 998.858M | 953.927M | 641.498M | 485.892M | 422.24M |
Other Current Liab | 97.142M | 99.796M | 3M | 4.291M | 57.886M |
Common Stock | 0.038M | 0.037M | 0.036M | 0.035M | 0.034M |
Capital Stock | 0.038M | 0.037M | 0.036M | 0.035M | 0.034M |
Retained Earnings | 43.904M | 45.906M | 40.622M | 57.522M | 9.064M |
Good Will | 166.046M | 166.388M | 8.372M | 7.656M | 7.813M |
Other Assets | 77.006M | 78.683M | 138.101M | 34.251M | 33.815M |
Cash | 69.858M | 59.379M | 69.67M | 72.779M | 67.85M |
Cash And Equivalents | 69.858M | 59.379M | 69.67M | 72.779M | 67.85M |
Total Current Liabilities | 144.932M | 123.197M | 105.932M | 91.048M | 66.062M |
Current Deferred Revenue | 9.158M | - | 82.795M | 63.339M | - |
Net Debt | 165.915M | 114.169M | 7.607M | 9.518M | -67.85M |
Short Term Debt | 11.953M | 9.98M | 6.028M | 8.307M | 0M |
Short Long Term Debt | - | - | - | - | - |
Short Long Term Debt Total | 235.773M | 173.548M | 77.277M | 82.297M | - |
Other Stockholder Equity | 963.04M | 910.614M | 598.299M | 430.659M | 415.084M |
Property Plant Equipment | 290.974M | 227.087M | 48.169M | 131.923M | 32.612M |
Total Current Assets | 755.699M | 681.474M | 617.702M | 463.134M | 410.726M |
Long Term Investments | - | - | - | - | 0M |
Short Term Investments | 118.172M | 195.496M | 195.162M | 116.61M | 133.039M |
Net Receivables | 203.384M | 133.94M | 114.608M | 105.901M | 81.896M |
Long Term Debt | - | - | - | - | - |
Inventory | 334.006M | 263.504M | 219.527M | 152.992M | 115.741M |
Accounts Payable | 26.679M | 13.421M | 14.109M | 15.111M | 8.176M |
Accumulated Other Comprehensive Income | -8.124M | -2.63M | 2.541M | -2.324M | -1.942M |
Non Currrent Assets Other | 12.793M | 12.985M | 8.705M | 2.946M | 0.875M |
Non Current Assets Total | 615.187M | 562.776M | 205.281M | 202.767M | 104.28M |
Capital Lease Obligations | 235.773M | 173.548M | 77.277M | 82.297M | - |
Long Term Debt Total | 24.865M | 26.523M | 27.066M | 26.748M | 0M |
Cash Flow
(Currency in USD)Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
---|---|---|---|---|---|
Investments | 74.088M | -3.074M | -76.333M | 18.034M | 29.632M |
Total Cashflows From Investing Activities | 54.79M | -21.735M | -104.149M | -12.711M | -0.385M |
Total Cash From Financing Activities | 11.622M | 0.836M | 134.917M | -8.959M | -9.815M |
Net Income | -2.002M | 2.623M | -19.257M | 47.004M | 2.91M |
Change In Cash | 10.479M | -10.291M | -3.109M | 4.929M | 17.213M |
Begin Period Cash Flow | 59.379M | 69.67M | 72.779M | 67.85M | 50.637M |
End Period Cash Flow | 69.858M | 59.379M | 69.67M | 72.779M | 67.85M |
Total Cash From Operating Activities | -55.661M | 9.502M | -33.242M | 26.652M | 28.808M |
Depreciation | 24.321M | 16.408M | 12.891M | 8.104M | 6.168M |
Other Cashflows From Investing Activities | 74.088M | -0.4M | -3.06M | -8.636M | -20.414M |
Dividends Paid | - | - | - | - | - |
Change To Inventory | -74.631M | -51.554M | -56.981M | -41.407M | -22.288M |
Sale Purchase Of Stock | 21.552M | 18.369M | 151.298M | 13.904M | 12.795M |
Other Cashflows From Financing Activities | -0.393M | -11.418M | 3.576M | -15.373M | -16.642M |
Capital Expenditures | 19.298M | 21.18M | 24.756M | 22.109M | 9.603M |
Change In Working Capital | -121.798M | -70.419M | -51.19M | -56.842M | -30.26M |
Other Non Cash Items | 4.982M | 9.218M | 17.591M | 5.081M | 38.048M |
Free Cash Flow | -74.959M | -11.678M | -57.998M | 4.543M | 19.205M |
Funds
Sr. No. | Name | Purchased On | Shares |
---|---|---|---|
1. | iShares Core S&P Mid-Cap ETF | 3 months ago | 1182102 |
2. | Capital Group AMCAP Composite | 5 months ago | 1167199 |
3. | VA CollegeAmerica Amcap 529A | 5 months ago | 1167199 |
4. | Vanguard Total Stock Mkt Idx Inv | 3 months ago | 1146027 |
5. | Select Health Care | 4 months ago | 1120000 |
6. | Select Medical Tech and Devcs | 4 months ago | 1020000 |
7. | Vanguard Small Cap Index | 3 months ago | 945951 |
8. | Fidelity Advisor® Health Care I | 4 months ago | 750000 |
9. | T. Rowe Price Health Sciences | 5 months ago | 739477 |
10. | American Funds SMALLCAP World A | 5 months ago | 713902 |
11. | Capital Group Growth Fnd of Amer Comp | 5 months ago | 586015 |
12. | American Funds Growth Fund of Amer A | 5 months ago | 586015 |
13. | Vanguard Institutional Extnd Mkt Idx Tr | 3 months ago | 557722 |
14. | Vanguard Small Cap Growth Index Inv | 3 months ago | 529594 |
15. | ClearBridge Small Cap Growth A | 5 months ago | 486367 |
16. | American Funds Capital World Gr&Inc A | 5 months ago | 468963 |
17. | Capital Group World Growth & Inc Cmp | 5 months ago | 468963 |
18. | Strategic Advisers® Fidelity US TtlStk | 4 months ago | 412700 |
19. | ClearBridge Small Cap Growth | 4 months ago | 408095 |
20. | Champlain Small Company Fund, LLC | 3 months ago | 376610 |
Institutions
Sr. No. | Name | Purchased On | Shares |
---|---|---|---|
1. | FMR Inc | 5 months ago | 5016984 |
2. | BlackRock Inc | 5 months ago | 4260650 |
3. | Vanguard Group Inc | 5 months ago | 3599919 |
4. | Capital Research Global Investors | 5 months ago | 2677510 |
5. | T. Rowe Price Associates, Inc. | 5 months ago | 1963783 |
6. | State Street Corporation | 5 months ago | 1060054 |
7. | ClearBridge Advisors, LLC | 5 months ago | 905222 |
8. | Baillie Gifford & Co Limited. | 5 months ago | 679627 |
9. | RTW INVESTMENTS, LLC | 5 months ago | 673371 |
10. | William Blair Investment Management, LLC | 5 months ago | 656964 |
11. | Geode Capital Management, LLC | 5 months ago | 572809 |
12. | Amvescap Plc. | 5 months ago | 551923 |
13. | Capital World Investors | 5 months ago | 543274 |
14. | Rock Springs Capital Management LP | 5 months ago | 503750 |
15. | Morgan Stanley - Brokerage Accounts | 5 months ago | 353685 |
16. | Eagle Asset Management, Inc. | 5 months ago | 353450 |
17. | Champlain Investment Partners, LLC | 5 months ago | 353390 |
18. | Bank of New York Mellon Corp | 5 months ago | 333045 |
19. | Franklin Resources Inc | 5 months ago | 292075 |
20. | HHG PLC | 5 months ago | 270483 |
Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).